Serpin Pharma, Inc. Announces Approval to Initiate EASE AKI Phase II Clinical Trial in Germany
MANASSAS, VA, UNITED STATES, February 16, 2026 /EINPresswire.com/ -- Serpin Pharma, Inc., a clinical stage biopharmaceutical company developing first in class LRP1 agonist therapeutics, today announced that its Phase II clinical trial, EASE-AKI, has …